The Hungarian Government today announced that generic and specialty drug-maker Mylan Inc. will establish a pharmaceutical packaging center in the Komarom Industrial Park. The project is expected to add approximately 400 new jobs to the local economy over the next several years.

“Hungary needs such investments and such innovations that strengthen the Hungarian economy. Those do not destroy, but undisputedly build our country based on Hungarian small and medium-sized enterprises” - emphasized State Secretary for External Trade Relations of the Hungarian Government Zsolt Becsey at the investment announcement press conference on Thursday.

Mylan Chief Operating Officer Rajiv Malik commented: “We are very pleased to be expanding Mylan’s operations and presence in Hungary. After conducting a broad search for a suitable facility with the potential to expand, the opportunity in Komarom turned out to be an ideal fit. Not long from now, we’ll have a high quality, efficient packaging operation up and running that will be able to support our dynamic business and the local economy. Because our primary focus is to help provide pharmaceuticals to the world’s seven billion people, we are also looking forward to increasing our market share of high quality pharmaceuticals across the country.”

Mylan has acquired a 10,000 m2 facility in Komarom. The facility will be modified to become a packaging center for oral solid dosage tablets and capsules received from the company’s manufacturing sites. The project will be limited to packaging, warehousing and support functions such as quality control laboratories. Over the next five years, the center will be equipped with blister packaging lines, bottling lines and high potency drug packaging lines. The project also will involve the construction of a 17,500 m2 warehouse facility.

The entire operation will meet all good manufacturing practice (GMP) specifications of the European Medicines Agency, the U.S. Food and Drug Administration and the National Institute of Pharmacy in Hungary.

About Mylan

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.